Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
7,617,701 6.600% |
-3,458,214 (-31.22%) |
Filing History |
| 2025-04-16 5:37 pm Purchase |
2025-04-14 | 13G | Coherus BioSciences, Inc. CHRS |
Thomas A. Satterfield, Jr. | 6,009,514 5.200% |
6,009,514 (New Position) |
Filing History |
| 2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Rubric Capital Management LP | 5,258,754 4.560% |
-5,141,246 (-49.44%) |
Filing History |
| 2025-02-05 1:23 pm Sale |
2024-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
11,075,915 9.600% |
-998,780 (-8.27%) |
Filing History |
| 2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Coherus BioSciences, Inc. CHRS |
Rubric Capital Management LP | 10,400,000 9.030% |
10,400,000 (New Position) |
Filing History |
| 2024-07-23 08:23 am Sale |
2024-07-17 | 13G | Coherus BioSciences, Inc. CHRS |
Temasek Holdings (Private) Ltd | 5,536,949 4.800% |
-683,603 (-10.99%) |
Filing History |
| 2024-05-22 7:27 pm Sale |
2024-05-20 | 13G | Coherus BioSciences, Inc. CHRS |
Temasek Holdings (Private) Ltd | 6,220,552 5.400% |
-1,160,564 (-15.72%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Citadel Advisors LLC | 2,047,286 1.800% |
-3,767,788 (-64.79%) |
Filing History |
| 2024-02-14 3:00 pm Sale |
2024-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 156,000 0.100% |
-6,023,005 (-97.48%) |
Filing History |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Coherus BioSciences, Inc. CHRS |
The Vanguard Group | 10,357,412 9.300% |
4,541,530 (+78.09%) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
12,074,695 10.800% |
428,860 (+3.68%) |
Filing History |
| 2024-01-22 2:08 pm Sale |
2023-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
STATE STREET CORP STT |
2,064,326 1.850% |
-4,721,656 (-69.58%) |
Filing History |
| 2023-12-07 2:45 pm Sale |
2023-11-30 | 13G | Coherus BioSciences, Inc. CHRS |
JPMORGAN CHASE & CO JPM |
124,796 0.100% |
-5,538,974 (-97.80%) |
Filing History |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
11,645,835 10.900% |
-2,433,066 (-17.28%) |
Filing History |
| 2023-05-19 09:15 am Purchase |
2023-05-18 | 13G | Coherus BioSciences, Inc. CHRS |
Citadel Advisors LLC | 5,815,074 6.200% |
5,815,074 (New Position) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Perceptive Advisors LLC | 0 0.000% |
-5,407,798 (Position Closed) |
Filing History |
| 2023-02-13 7:15 pm Purchase |
2023-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 6,179,005 8.000% |
510,477 (+9.01%) |
Filing History |
| 2023-02-09 11:15 am Purchase |
2022-12-30 | 13G | Coherus BioSciences, Inc. CHRS |
The Vanguard Group | 5,815,882 7.480% |
1,268,353 (+27.89%) |
Filing History |
| 2023-02-03 4:00 pm Purchase |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
STATE STREET CORP STT |
6,785,982 8.720% |
2,964,862 (+77.59%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
14,078,901 18.100% |
0 (Unchanged) |
Filing History |